TIFA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.286240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.352260E-02
Normal-vs-Stage2
1.323230E-01
Normal-vs-Stage3
1.300610E-01
Normal-vs-Stage4
3.695700E-02
Stage1-vs-Stage2
8.379800E-01
Stage1-vs-Stage3
9.930800E-01
Stage1-vs-Stage4
8.228600E-01
Stage2-vs-Stage3
8.725600E-01
Stage2-vs-Stage4
6.821800E-01
Stage3-vs-Stage4
8.002600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.295200E-01
Normal-vs-AfricanAmerican
2.540200E-02
Normal-vs-Asian
1.049570E-01
Caucasian-vs-AfricanAmerican
3.658600E-01
Caucasian-vs-Asian
1.806190E-01
AfricanAmerican-vs-Asian
3.010200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.78260000003061E-06
Normal-vs-Female
1.369770E-01
Male-vs-Female
2.251800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.874300E-02
Normal-vs-Age(41-60Yrs)
1.330220E-01
Normal-vs-Age(61-80Yrs)
5.93789999999705E-05
Normal-vs-Age(81-100Yrs)
1.164390E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.858800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.259000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.995000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.519800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.969450E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.892000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.376300E-04
Normal-vs-Daily Drinker
1.042760E-01
Normal-vs-Weekly Drinker
1.143600E-01
Normal-vs-Occasional Drinker
1.293400E-01
Normal-vs-Social Drinker
1.164160E-03
Non Drinker-vs-Daily Drinker
7.717800E-02
Non Drinker-vs-Weekly Drinker
3.417800E-01
Non Drinker-vs-Occasional Drinker
9.219200E-01
Non Drinker-vs-Social Drinker
7.338000E-01
Daily Drinker-vs-Weekly Drinker
3.917000E-01
Daily Drinker-vs-Occasional Drinker
1.383390E-01
Daily Drinker-vs-Social Drinker
7.490300E-02
Weekly Drinker-vs-Occasional Drinker
4.655400E-01
Weekly Drinker-vs-Social Drinker
2.541200E-01
Occasional Drinker-vs-Social Drinker
6.749600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.812400E-01
Normal-vs-Grade 2
1.392430E-01
Normal-vs-Grade 3
2.394200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.700600E-01
Grade 1-vs-Grade 3
7.793600E-01
Grade 1-vs-Grade 4
3.812400E-01
Grade 2-vs-Grade 3
6.568200E-01
Grade 2-vs-Grade 4
1.392430E-01
Grade 3-vs-Grade 4
2.394200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.572170E-04
Normal-vs-NonDiabetic
1.167230E-01
Diabetic-vs-NonDiabetic
4.447600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.121370E-01
Normal-vs-NoPancreatitis
1.259820E-01
Pancreatitis-vs-NoPancreatitis
3.251000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.431500E-04
Normal-vs-N1
1.312230E-01
N0-vs-N1
6.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.560620E-01
Normal-vs-TP53-NonMutant
1.992450E-01
TP53-Mutant-vs-TP53-NonMutant
5.722300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
